ImmunoGen
Bookmark
ShareImmunoGen is a company. It is in Waltham, the United States and it has a male CEO called Mark Joseph Enyedy. It was founded in 1981 and is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Waltham
- state: MA
- country: United States
- employees: 106 people
- revenues: 89.4M $
- sector: Health Care
- industry: Biotechnology
- foundation year: 1981
- CEO: Mark Joseph Enyedy
- CEO gender: male
- CEO approval: 93 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about ImmunoGen:
Stocks from ImmunoGen:
ImmunoGen is one of the companies in Mark Joseph Enyedy, companies in the United States, companies in Biotechnology, companies in Health Care and 3,584,319 companies in our database.
Talking Points
- Attention Required! | Cloudflare
- Interrupting the progress of cancer so cancer can't interrupt the lives of our patients. | Targeting a better life for people with cancer is why we get up in the morning. It's not enough to disrupt the progress of someone's cancer; we want to keep cancer from disrupting someone's life. That's why everything we do is about developing the ...
- ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
